New scientific evidence challenges the alleged cognitive benefits of brain-training games. Exercise and sleep may be better ways to boost cognition.
Action items that may improve PD status
- evidence-based
- Root causes may play a role in many conditions, in all causes listed below, a link to PD was found
- Key items in the list include: Keto, Fasting, Intermittent fasting, FMD, mitochondria support, micronutrient optimization/supplementation, macro’s, pathogens, poisons, mind-body, motor learning, masticking, vibration therapy, diet, exercise, EMF radiation dysbiosis & licky gut. cold/ heat exposure, hormetic stressors, sleep optimization.
- The goal of the list is to map causes and available treatments relevant to the condition.
- This is a work in progress, adding new items all the time (sign up for updates)
- Visit https://healthlinks.cc/list/meds/pd-meds/ for the meds related
electrolytes including sodium, calcium, potassium, magnesium, and chloride negativly asssociated with Dyskinesia in PD
Stem Cell – Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies – IOS Press
Current approaches to cell replacement therapy in Parkinson’s disease are strongly focused on the dopamine system, with the view that restoring dopaminergic inputs in a localized and physiologic manner will provide superior benefits in terms of effec
Source: Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies – IOS Press
CBD – Cannabinoids in PD
Fetal tissue implant – Wikipedia
Source: Fetal tissue implant – Wikipedia
…In 1982, seven people in Santa Clara County, California were diagnosed with Parkinsonism after having used MPPP contaminated with MPTP. In 1992, two of the seven patients were successfully treated at Lund University Hospital in Sweden with neural grafts of fetal tissue. One patient, who had been essentially paralyzed, regained enough motor function to ride a bicycle.[1]
Diabetes protocol
High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease – IOS Press
Background: Reduced glucose tolerance has been long recognized as a potential risk factor for Parkinson’s disease (PD), and increasing scrutiny is currently being placed on insulin resistance (IR) as a pathologic driver of neurodegeneration. However,
for comparison, prevalence of Diabetes in the general population:
its high – 20% suggesting much higher prevalence of IR, not sure if IR in PD is that much above normal
Whole body vibration: Neuro-rehab applications
2-deoxy-D-glucose is noeroprotective
www.ncbi.nlm.nih.gov/pubmed/10398297
2-deoxy-D-glucose (2-DG; a nonmetabolizable analogue of glucose) to mice fed ad libitum. Mice receiving 2-DG exhibited reduced damage to dopaminergic neurons in the SN and improved behavioral outcome following MPTP treatment.
Increased intestinal permeability and Parkinson disease patients
Herbal Antibiotics
Herbal Antivirals
Functional Neurological Disorders
postpone (vegan source) protein intake until evening
N-hexacosanol and fisetin
Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy
Corynoxine, isolated from Uncaria rhynchophylla, promotes the clearance of alpha-synuclein
Corynoxine, isolated from Uncaria rhynchophylla, promotes the clearance of alpha-synuclein
www.ncbi.nlm.nih.gov/pubmed/24522518
Corynoxine, isolated from Uncaria rhynchophylla, promotes the clearance of alpha-synuclein via mTOR pathway [R].
use of Uncaria rhynchophylla, known as “Gou-teng” herb extract
examine.com/supplements/uncaria-rhynchophylla/
www.ncbi.nlm.nih.gov/pubmed/29940559
buy uncaria-rhynchophylla:
buy Corynoxine:
www.alibaba.com/trade/search?fsb=y&IndexArea=product_en&CatId=&SearchText=Corynoxine
Q10
Action item:
q10 1200mg/day
Creatine
Mucuna pruriens – Levedopa
Type 2 diabetes is associated with an increased risk of PD
type 2 diabetes is associated with an increased risk of Parkinson’s disease. Surveillance bias might account for higher rates in diabetes. The mechanism behind this association between diabetes and disease is not known
care.diabetesjournals.org/content/early/2007/01/24/dc06-2011.short